FAPI PET/CT is a novel imaging tool targeting fibroblast activation protein (FAP), with high
tumor uptake rate and low background noise. Therefore, the appearance of FAPI PET/CT …

Please see the Editorial Comment by Sree Harsha Tirumani discussing this article.
BACKGROUND. FDG PET/CT has limited diagnostic performance in the detection of …

Background Mesenchymal Consensus Molecular Subtype 4 (CMS4) colon cancer is
associated with poor prognosis and therapy resistance. In this proof-of-concept study, we …

The increasing detection of colorectal adenomas and early adenocarcinomas (ADCs) in the
context of nationwide screening programs has led to a significant increase in the incidence …

Purpose This study aims to review the multifaceted roles of a membrane protein named
Fibroblast Activation Protein (FAP) expressed in tumor tissue, including its molecular …

Background The determinants of metastasis in mismatch repair deficiency with high levels of
microsatellite instability (MSI-H) in colorectal cancer (CRC) are poorly understood. Here, we …

Over the past decade, our understanding of the diversity of colorectal cancer has expanded
significantly, raising hopes of tailoring treatments more precisely for individual patients. A …

Abstract FAPI PET/CT, an innovative medical imaging technique, has emerged as a
promising method to target fibroblast activation protein (FAP). This novel approach offers …

Purpose To compare performance of whole-body [68Ga] Ga-FAPI-04 and [18F] FDG PET
imaging in the detection of Krukenberg tumors (KTs), primary site and extra-ovarian …

Background Palliative systemic therapy alternated with electrostatic precipitation oxaliplatin-
based pressurized intraperitoneal aerosol chemotherapy (ePIPAC) has never been …